Neuropsychometric outcome predictors for adults with maple syrup urine disease

Area of Science:

• Biochemistry
• Genetics
• Neurology

Background:

• Maple Syrup Urine Disease (MSUD) is a rare inherited metabolic disorder.
• MSUD is characterized by the inability to metabolize branched-chain amino acids (BCAAs), leading to their toxic accumulation.
• Varied clinical presentations and outcomes are observed in MSUD patients.

Purpose of the Study:

• To investigate the long-term clinical and neuropsychometric outcomes in adult patients with MSUD.
• To determine predictors of intellectual quotient (IQ) in adult MSUD patients.
• To explore the relationship between long-term blood leucine levels and cognitive function in adults with MSUD.

Main Methods:

• Retrospective analysis of 14 adult MSUD patients, including 3 with intermediate MSUD.
• Assessment of clinical data and neuropsychometric outcomes.
• Correlation analysis between age at diagnosis, long-term blood leucine levels, and IQ scores.

Main Results:

• Age at diagnosis was found to be a significant predictor of IQ in adult MSUD patients.
• Long-term blood leucine levels did not show a correlation with IQ in this cohort.
• A wide range of clinical and neuropsychometric outcomes were observed among the patients.

Conclusions:

• Early diagnosis is crucial for optimizing cognitive outcomes in MSUD.
• Monitoring long-term leucine levels may not be sufficient for predicting cognitive function in adult MSUD patients.
• Further research is needed to understand the complex factors influencing long-term outcomes in MSUD.